整形外科腫瘍治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2633)
◆英語タイトル:Global Orthopedic Oncology Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2633
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:106
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、整形外科腫瘍治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(軟部組織切除/切除、患肢救済手術、切断、補助化学療法、再建手術)、用途別市場規模(病院、クリニック、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・整形外科腫瘍治療の市場動向
・企業の競争状況、市場シェア
・整形外科腫瘍治療の種類別市場規模(軟部組織切除/切除、患肢救済手術、切断、補助化学療法、再建手術)
・整形外科腫瘍治療の用途別市場規模(病院、クリニック、その他)
・整形外科腫瘍治療の北米市場規模2016-2027(アメリカ、カナダ)
・整形外科腫瘍治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・整形外科腫瘍治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・整形外科腫瘍治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・整形外科腫瘍治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Stryker Corporation、Zimmer Biomet Holdings, Inc.、Smith & Nephew plc、DePuy Synthes (Johnson & Johnson)、Medtronic、Accentus Medical、Roche Holding AG、Amgen, Inc.、Novartis AG、GlaxoSmithKline、Sanofi、Pfizer Inc.)
・結論
【レポートの概要】

Orthopedic oncology accounts for a very small percentage in the field of orthopedics due to fact that the incidences of bone and soft tissue tumors are rare as compared to the benign tumors of musculoskeletal system which includes trauma, spine, hand and upper extremity, total joints and even pediatric orthopedics.

Market Analysis and Insights: Global Orthopedic Oncology Treatment Market
The global Orthopedic Oncology Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Orthopedic Oncology Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Orthopedic Oncology Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Orthopedic Oncology Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Orthopedic Oncology Treatment market.

Global Orthopedic Oncology Treatment Scope and Market Size
Orthopedic Oncology Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Orthopedic Oncology Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Soft Tissue Excisions/Resections
Limb Salvage Surgery
Amputation
Adjuvant Chemotherapy
Reconstructive Surgery

Segment by Application
Hospitals
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Stryker Corporation
Zimmer Biomet Holdings, Inc.
Smith & Nephew plc
DePuy Synthes (Johnson & Johnson)
Medtronic
Accentus Medical
Roche Holding AG
Amgen, Inc.
Novartis AG
GlaxoSmithKline
Sanofi
Pfizer Inc.

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Orthopedic Oncology Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Soft Tissue Excisions/Resections
1.2.3 Limb Salvage Surgery
1.2.4 Amputation
1.2.5 Adjuvant Chemotherapy
1.2.6 Reconstructive Surgery
1.3 Market by Application
1.3.1 Global Orthopedic Oncology Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Orthopedic Oncology Treatment Market Perspective (2016-2027)
2.2 Orthopedic Oncology Treatment Growth Trends by Regions
2.2.1 Orthopedic Oncology Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Orthopedic Oncology Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Orthopedic Oncology Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Orthopedic Oncology Treatment Industry Dynamic
2.3.1 Orthopedic Oncology Treatment Market Trends
2.3.2 Orthopedic Oncology Treatment Market Drivers
2.3.3 Orthopedic Oncology Treatment Market Challenges
2.3.4 Orthopedic Oncology Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Orthopedic Oncology Treatment Players by Revenue
3.1.1 Global Top Orthopedic Oncology Treatment Players by Revenue (2016-2021)
3.1.2 Global Orthopedic Oncology Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Orthopedic Oncology Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Orthopedic Oncology Treatment Revenue
3.4 Global Orthopedic Oncology Treatment Market Concentration Ratio
3.4.1 Global Orthopedic Oncology Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Orthopedic Oncology Treatment Revenue in 2020
3.5 Orthopedic Oncology Treatment Key Players Head office and Area Served
3.6 Key Players Orthopedic Oncology Treatment Product Solution and Service
3.7 Date of Enter into Orthopedic Oncology Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Orthopedic Oncology Treatment Breakdown Data by Type
4.1 Global Orthopedic Oncology Treatment Historic Market Size by Type (2016-2021)
4.2 Global Orthopedic Oncology Treatment Forecasted Market Size by Type (2022-2027)

5 Orthopedic Oncology Treatment Breakdown Data by Application
5.1 Global Orthopedic Oncology Treatment Historic Market Size by Application (2016-2021)
5.2 Global Orthopedic Oncology Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Orthopedic Oncology Treatment Market Size (2016-2027)
6.2 North America Orthopedic Oncology Treatment Market Size by Type
6.2.1 North America Orthopedic Oncology Treatment Market Size by Type (2016-2021)
6.2.2 North America Orthopedic Oncology Treatment Market Size by Type (2022-2027)
6.2.3 North America Orthopedic Oncology Treatment Market Size by Type (2016-2027)
6.3 North America Orthopedic Oncology Treatment Market Size by Application
6.3.1 North America Orthopedic Oncology Treatment Market Size by Application (2016-2021)
6.3.2 North America Orthopedic Oncology Treatment Market Size by Application (2022-2027)
6.3.3 North America Orthopedic Oncology Treatment Market Size by Application (2016-2027)
6.4 North America Orthopedic Oncology Treatment Market Size by Country
6.4.1 North America Orthopedic Oncology Treatment Market Size by Country (2016-2021)
6.4.2 North America Orthopedic Oncology Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Orthopedic Oncology Treatment Market Size (2016-2027)
7.2 Europe Orthopedic Oncology Treatment Market Size by Type
7.2.1 Europe Orthopedic Oncology Treatment Market Size by Type (2016-2021)
7.2.2 Europe Orthopedic Oncology Treatment Market Size by Type (2022-2027)
7.2.3 Europe Orthopedic Oncology Treatment Market Size by Type (2016-2027)
7.3 Europe Orthopedic Oncology Treatment Market Size by Application
7.3.1 Europe Orthopedic Oncology Treatment Market Size by Application (2016-2021)
7.3.2 Europe Orthopedic Oncology Treatment Market Size by Application (2022-2027)
7.3.3 Europe Orthopedic Oncology Treatment Market Size by Application (2016-2027)
7.4 Europe Orthopedic Oncology Treatment Market Size by Country
7.4.1 Europe Orthopedic Oncology Treatment Market Size by Country (2016-2021)
7.4.2 Europe Orthopedic Oncology Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Orthopedic Oncology Treatment Market Size (2016-2027)
8.2 Asia-Pacific Orthopedic Oncology Treatment Market Size by Type
8.2.1 Asia-Pacific Orthopedic Oncology Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Orthopedic Oncology Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Orthopedic Oncology Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Orthopedic Oncology Treatment Market Size by Application
8.3.1 Asia-Pacific Orthopedic Oncology Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Orthopedic Oncology Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Orthopedic Oncology Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Orthopedic Oncology Treatment Market Size by Region
8.4.1 Asia-Pacific Orthopedic Oncology Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Orthopedic Oncology Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Orthopedic Oncology Treatment Market Size (2016-2027)
9.2 Latin America Orthopedic Oncology Treatment Market Size by Type
9.2.1 Latin America Orthopedic Oncology Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Orthopedic Oncology Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Orthopedic Oncology Treatment Market Size by Type (2016-2027)
9.3 Latin America Orthopedic Oncology Treatment Market Size by Application
9.3.1 Latin America Orthopedic Oncology Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Orthopedic Oncology Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Orthopedic Oncology Treatment Market Size by Application (2016-2027)
9.4 Latin America Orthopedic Oncology Treatment Market Size by Country
9.4.1 Latin America Orthopedic Oncology Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Orthopedic Oncology Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Orthopedic Oncology Treatment Market Size (2016-2027)
10.2 Middle East & Africa Orthopedic Oncology Treatment Market Size by Type
10.2.1 Middle East & Africa Orthopedic Oncology Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Orthopedic Oncology Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Orthopedic Oncology Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Orthopedic Oncology Treatment Market Size by Application
10.3.1 Middle East & Africa Orthopedic Oncology Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Orthopedic Oncology Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Orthopedic Oncology Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Orthopedic Oncology Treatment Market Size by Country
10.4.1 Middle East & Africa Orthopedic Oncology Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Orthopedic Oncology Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Stryker Corporation
11.1.1 Stryker Corporation Company Details
11.1.2 Stryker Corporation Business Overview
11.1.3 Stryker Corporation Orthopedic Oncology Treatment Introduction
11.1.4 Stryker Corporation Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.1.5 Stryker Corporation Recent Development
11.2 Zimmer Biomet Holdings, Inc.
11.2.1 Zimmer Biomet Holdings, Inc. Company Details
11.2.2 Zimmer Biomet Holdings, Inc. Business Overview
11.2.3 Zimmer Biomet Holdings, Inc. Orthopedic Oncology Treatment Introduction
11.2.4 Zimmer Biomet Holdings, Inc. Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.2.5 Zimmer Biomet Holdings, Inc. Recent Development
11.3 Smith & Nephew plc
11.3.1 Smith & Nephew plc Company Details
11.3.2 Smith & Nephew plc Business Overview
11.3.3 Smith & Nephew plc Orthopedic Oncology Treatment Introduction
11.3.4 Smith & Nephew plc Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.3.5 Smith & Nephew plc Recent Development
11.4 DePuy Synthes (Johnson & Johnson)
11.4.1 DePuy Synthes (Johnson & Johnson) Company Details
11.4.2 DePuy Synthes (Johnson & Johnson) Business Overview
11.4.3 DePuy Synthes (Johnson & Johnson) Orthopedic Oncology Treatment Introduction
11.4.4 DePuy Synthes (Johnson & Johnson) Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.4.5 DePuy Synthes (Johnson & Johnson) Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Details
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Orthopedic Oncology Treatment Introduction
11.5.4 Medtronic Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.5.5 Medtronic Recent Development
11.6 Accentus Medical
11.6.1 Accentus Medical Company Details
11.6.2 Accentus Medical Business Overview
11.6.3 Accentus Medical Orthopedic Oncology Treatment Introduction
11.6.4 Accentus Medical Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.6.5 Accentus Medical Recent Development
11.7 Roche Holding AG
11.7.1 Roche Holding AG Company Details
11.7.2 Roche Holding AG Business Overview
11.7.3 Roche Holding AG Orthopedic Oncology Treatment Introduction
11.7.4 Roche Holding AG Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.7.5 Roche Holding AG Recent Development
11.8 Amgen, Inc.
11.8.1 Amgen, Inc. Company Details
11.8.2 Amgen, Inc. Business Overview
11.8.3 Amgen, Inc. Orthopedic Oncology Treatment Introduction
11.8.4 Amgen, Inc. Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.8.5 Amgen, Inc. Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Orthopedic Oncology Treatment Introduction
11.9.4 Novartis AG Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.9.5 Novartis AG Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Details
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Orthopedic Oncology Treatment Introduction
11.10.4 GlaxoSmithKline Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.10.5 GlaxoSmithKline Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Details
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Orthopedic Oncology Treatment Introduction
11.11.4 Sanofi Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.11.5 Sanofi Recent Development
11.12 Pfizer Inc.
11.12.1 Pfizer Inc. Company Details
11.12.2 Pfizer Inc. Business Overview
11.12.3 Pfizer Inc. Orthopedic Oncology Treatment Introduction
11.12.4 Pfizer Inc. Revenue in Orthopedic Oncology Treatment Business (2016-2021)
11.12.5 Pfizer Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 整形外科腫瘍治療の世界市場規模・現状・予測2021年-2027年(Global Orthopedic Oncology Treatment Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。